about
RASopathies: unraveling mechanisms with animal modelsMeningiomas occurring during long-term survival after treatment for childhood cancerMerlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survivalTomotherapy for neurofibromatosis Type 2: case report and review of the literature.Multiple schwannomas: report of two cases.Tamoxifen inhibits malignant peripheral nerve sheath tumor growth in an estrogen receptor-independent mannerIncreased noise as an effect of haploinsufficiency of the tumor-suppressor gene neurofibromatosis type 1 in vitro.Nf1 RasGAP inhibition of LIMK2 mediates a new cross-talk between Ras and Rho pathwaysAdrenal cancer in neurofibromatosis type 1: case report and DNA analysisPheochromocytoma: the expanding genetic differential diagnosis.Ossifying fibromyxoid tumor of soft parts: a clinicopathologic, proteomic, and genomic study.Genetics of neurofibromatosis 1-associated peripheral nerve sheath tumors.The pan erbB inhibitor PD168393 enhances lysosomal dysfunction-induced apoptotic death in malignant peripheral nerve sheath tumor cellsTumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors. I. The role of tumor suppressor mutations.Tumor suppressor mutations and growth factor signaling in the pathogenesis of NF1-associated peripheral nerve sheath tumors: II. The role of dysregulated growth factor signaling.Neurofibromatosis type 1 associated with pheochromocytoma: a case report and a review of the literature.How does the Schwann cell lineage form tumors in NF1?Neurooncology of familial cancer syndromes.Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-LQuantitative Proteomics Reveals Fundamental Regulatory Differences in Oncogenic HRAS and Isocitrate Dehydrogenase (IDH1) Driven Astrocytoma.Ral overactivation in malignant peripheral nerve sheath tumors.Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors.Alterations of protein 4.1 family members in ependymomas: a study of 84 cases.Neurofibromatosis 1: a novel NF1 mutation in an 11-year-old girl with a giant cell granuloma.Differential gene expression between human schwannoma and control Schwann cells.
P2860
Q26800379-DE018797-8A08-44CA-A7B1-096E4EB47C9CQ26829620-439F4931-9D7D-49E3-8DD4-E9441196A022Q28283076-C1CE475A-EB68-4523-8AEF-7FE5996D28A6Q30462284-2F9DBC5E-09E4-400D-9F6F-DFF3F3339D4EQ30492334-E410E6B7-CC3F-4AF8-BA03-1A1DC9ABE30FQ33746249-1CA0F0DF-8DCB-404A-9527-90711E0C3ED0Q34161443-51F65EEE-0155-450D-9985-9FB2AD73E134Q34452042-0398C580-E80F-4129-B884-412E0FE4A2F3Q34561573-AA326E71-2BC7-4885-A089-165F791E600AQ35203185-8341CAD0-DA81-4DB0-9285-21C43FC82D6DQ35350535-21F69F34-BF1E-4DC8-ACA1-1C79C8F7D555Q35634817-6CF7F284-B3A7-480D-A420-568ED8B05867Q35760676-5E02184D-01AF-4B35-8A68-79E41A7A819AQ35973936-070AB652-4767-4283-BD5F-09F301DA4371Q36044165-30E203D7-7BAC-45D0-9A29-4401A35D4399Q36743487-F3222187-CA7A-44BB-A678-08F9EE225731Q37120518-C027CCA7-D6E7-43C9-90D1-FC6B86A221DBQ37643115-C9C3E203-309B-4490-AAB3-14763C948099Q37709703-1CB54D22-1594-4D04-A386-7E22FF5C1A14Q38731795-08B39A49-70AE-4AAA-980A-DE99DD75D965Q39856973-07830312-286A-4836-B1B9-C638D87C3870Q42918689-5A8C4C14-68FF-4A1E-9946-A10B44BBD7DFQ46494065-6EA6EDD9-F0FA-4909-AC6B-C50520694B68Q49018540-F194C1AB-496E-4449-A8FA-CE1CE5CEB866Q50762436-A342E596-2A4C-425E-9BC4-B8691AC5BF63Q54573044-58F9F509-23DD-4E53-AD9C-9A3A328F87B4
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The neurofibromatoses: when less is more.
@ast
The neurofibromatoses: when less is more.
@en
The neurofibromatoses: when less is more.
@nl
type
label
The neurofibromatoses: when less is more.
@ast
The neurofibromatoses: when less is more.
@en
The neurofibromatoses: when less is more.
@nl
prefLabel
The neurofibromatoses: when less is more.
@ast
The neurofibromatoses: when less is more.
@en
The neurofibromatoses: when less is more.
@nl
P356
P1476
The neurofibromatoses: when less is more.
@en
P2093
Gutmann DH
P304
P356
10.1093/HMG/10.7.747
P577
2001-04-01T00:00:00Z